Singapore's Temasek sees three India portfolio companies surge over 30% after IPOs this week, contrasting with broader foreign investor skepticism
Singapore state investor Temasek Holdings' portfolio companies Shiprocket, Milky Mist, and Molbio Diagnostics recorded gains of 35%, 40%, and 26% respectively following their market debuts this week. This performance highlights Temasek's contrarian bet on India, where it has deployed nearly $9 billion in the last three years, bringing its total exposure to $42 billion. This stands in contrast to other foreign investors, who sold nearly $19 billion in Indian equities last year and have been net sellers for most of this year, with a BofA Global Research survey identifying India as the least favored market in Asia.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Taiwan Capitalization Weighted Stock Index fell 3.31% from the previous close, currently trading at 38,864.60.
-
2
Hang Seng Index fell 1.52% from its previous close, currently trading at 22,941.09
-
3
CRO (Cronos) Price Pulls Back to $0.04135, Hitting Nearly 365-Day Low
-
4
The Taiwan Capitalization Weighted Stock Index (TAIEX) fell 3.81% from its previous close, currently standing at 38,665.32.
-
5
The Shanghai Composite Index fell 1.05% from its previous close, currently trading at 3,550.32.
-
6
Bloomberg: A-Cap's flagship life insurer seeks to defer policyholder payments while exploring sale
-
7
What is PESA coin? Where to trade and buy PESA coin?
-
8
CoinDesk: Nasdaq futures up nearly 2%; Anthropic indicative quotes briefly 24% higher
-
9
Financial Times: Anthropic Discloses Activation of Measures Under 'Responsible Scaling Policy'
-
10
Bloomberg: Anthropic IPO Benefits SK Telecom's Early Investment, Reports Estimate Returns Around $3 Billion
Markets Today
Recommended Reading



